Raj Stewart, PhD

Across our national healthcare system, stakeholders ranging from clinicians to payers rely on shared, and differing, measures of value to determine which existing and emerging technologies will best serve patient needs. While medtech is experiencing a golden age of innovation, driven by breakthroughs in artificial intelligence integration; personalized medicine; and the use of wearables and implantables that treat and/or diagnose while generating novel data, a need still exists for collecting and communicating clinical, safety, and qualitative patient outcomes benefits in ways that resonate with the gatekeepers who control access to the healthcare marketplace. In this environment, it is critical to know how to position medtech products and leverage thoughtful planning and creative strategies to unlock coverage and reimbursement. Moderated by Ann Mayer, Senior Principal, IQVIA US Medtech Consulting practice, this panel will feature experts from health technology assessment, medtech regulatory, and payer perspectives discussing the present and near-future landscape for how manufacturers can optimize resonant evidence and convey value that leads to commercial success.